Back to today’s briefing

Story perspectives

Promising Niraparib Results Transform Aggressive Prostate Cancer Treatment

5/30/2025

37 3

Summary

Story summary

A Phase 2 trial at UC Davis has unveiled promising results for niraparib in treating aggressive prostate cancer, emphasizing the power of personalized medicine through genetic insights. In contrast, another study showed that adding radium-223 to radiotherapy offered no advantages for patients with bone metastases, underscoring the critical role of genetics in shaping effective cancer treatments.

1 of 1

Story summary

A Phase 2 trial at UC Davis has unveiled promising results for niraparib in treating aggressive prostate cancer, emphasizing the power of personalized medicine through genetic insights. In contrast, another study showed that adding radium-223 to radiotherapy offered no advantages for patients with bone metastases, underscoring the critical role of genetics in shaping effective cancer treatments.